HUT62197A - Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections - Google Patents

Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections Download PDF

Info

Publication number
HUT62197A
HUT62197A HU913022A HU302291A HUT62197A HU T62197 A HUT62197 A HU T62197A HU 913022 A HU913022 A HU 913022A HU 302291 A HU302291 A HU 302291A HU T62197 A HUT62197 A HU T62197A
Authority
HU
Hungary
Prior art keywords
fibroblast growth
growth factor
virus
use according
viral infections
Prior art date
Application number
HU913022A
Other languages
English (en)
Hungarian (hu)
Other versions
HU913022D0 (en
Inventor
Maria Antonietta Verini
Domenico Ungheri
Carlo Battistini
Paolo Carminati
Guy Mazue
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of HU913022D0 publication Critical patent/HU913022D0/hu
Publication of HUT62197A publication Critical patent/HUT62197A/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU913022A 1989-12-22 1990-12-18 Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections HUT62197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02280489A IT1237795B (it) 1989-12-22 1989-12-22 Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali.

Publications (2)

Publication Number Publication Date
HU913022D0 HU913022D0 (en) 1992-01-28
HUT62197A true HUT62197A (en) 1993-04-28

Family

ID=11200616

Family Applications (1)

Application Number Title Priority Date Filing Date
HU913022A HUT62197A (en) 1989-12-22 1990-12-18 Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections

Country Status (10)

Country Link
EP (1) EP0460161A1 (it)
JP (1) JPH04504581A (it)
AU (1) AU632890B2 (it)
CA (1) CA2047203A1 (it)
HU (1) HUT62197A (it)
IE (1) IE904593A1 (it)
IL (1) IL96667A0 (it)
IT (1) IT1237795B (it)
WO (1) WO1991009610A1 (it)
ZA (1) ZA9010337B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
DE60133767T2 (de) 2000-11-27 2009-06-25 Dnavec Research Inc., Tsukuba Für fibroblasten-wachstumsfaktor 2 (fgf2) kodierender paramyxovirus-vektor und dessen verwendung
JP6363833B2 (ja) * 2013-11-22 2018-07-25 ナノシータ株式会社 薄膜状高分子構造体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689845T3 (de) * 1985-09-12 2001-11-15 Scios Inc., Sunnyvale Rekombinanter fibroblast-wachstumsfaktor.
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials

Also Published As

Publication number Publication date
JPH04504581A (ja) 1992-08-13
IT8922804A0 (it) 1989-12-22
IL96667A0 (en) 1991-09-16
AU632890B2 (en) 1993-01-14
ZA9010337B (en) 1991-10-30
IE904593A1 (en) 1991-07-03
IT8922804A1 (it) 1991-06-22
HU913022D0 (en) 1992-01-28
CA2047203A1 (en) 1991-06-23
EP0460161A1 (en) 1991-12-11
WO1991009610A1 (en) 1991-07-11
AU6970491A (en) 1991-07-24
IT1237795B (it) 1993-06-17

Similar Documents

Publication Publication Date Title
US5288704A (en) Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent
AU617126B2 (en) A polypeptide growth factor from milk
KR20010033484A (ko) 각질세포 성장 인자-2 제제
JPH10509428A (ja) 活性依存性神経栄養因子の神経栄養ペプチド
CA2375829A1 (en) Keratinocyte growth factor-2 formulations
US5763406A (en) Method for the treatment of conditions caused by herpes virus infections
KR20180099546A (ko) 에리스로포이에틴 유래 펩티드의 세포손상방지에 효과를 통한 활용
CN102336815A (zh) 病毒感染的治疗
JPH0625007A (ja) Hbnfおよびmkタンパク質を使用するウイルスの感染を処置および阻止する方法
CN114773428A (zh) 新多肽及其在制备治疗皮肤创面或黏膜损伤药物中的应用
IE65533B1 (en) Hemoregulatory peptides
US6017880A (en) Inhibition of retrovirus infection
US5534495A (en) Treatment of non-HIV neuropathic pain syndromes
AU632890B2 (en) Fibroblast growth factor for use in the prevention and treatment of viral infections
CN117157308A (zh) 细胞穿膜肽变体及其用途
DE69332904T2 (de) Hemmung von hiv-infektion
US6869925B1 (en) Inhibition of retrovirus infection
WO1992021362A1 (en) Nerve growth factor for use in the prevention and treatment of viral infections
CA2202496C (en) Neurotrophic peptides of activity dependent neurotrophic factor
EP0557319B1 (en) Therapeutic use of fibroblast growth factor
JP2838867B2 (ja) 幹細胞増殖促進剤
US8178497B2 (en) Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA
JPH0820599A (ja) 新規なタンパク質

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee